KEAP1 and non-small cell lung carcinoma: Intriguingly, mining the TCGA NSCLC cohort, a significantly higher TMB and neoantigen load were observed in both KEAP1-mutant LUAD and LUSC (Figure 5); however, these features are not associated with a positive response to immunotherapy in this setting.